Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

NCT00005052 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: GM2-KLH vaccine
BIOLOGICAL: QS21
PROCEDURE: adjuvant therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC